BioTech Nation ... with Dr. Moira Gunn

Moira Gunn

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.

Listen in podnod RSS feed Show website

20 episodes
Updated Tuesday

Episodes20

Newest first

Tuesday · 18 min
A New Kind of Flu Shot...Dr. Jeff Stein, President & CEO, Cidara Therapeutics
This week on BioTech Nation, Dr. Jeff Stein, President & CEO of Cidara Therapeutics, brings up promising news about a new approach to flu shots.
July 21 · 24 min
A Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology
On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's unique approach to cancer immunotherapy, and how a discovery made over two decades ago started it all. Now, with a new drug entering Phase II human trials for Glioblastoma treatment, that discovery could mean a pathway to treating aggressive cancers...
July 14 · 14 min
Insulin-Producing Cells...with no Immunosuppressants?? Dr. Steve Harr, Sana Biotechnology
This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without the need for immunosuppressant drugs.
June 21 · 48 min
Looking Forward: Biotech in the Balance? Dr. Jeremy Levin, Bioentrepreneur & Former Chair, BIO
On this episode of BioTech Nation...The Biotech landscape is ever-evolving - but where are we headed?? Dr. Jeremy Levin, Physician, Bioentrepreneur, and Former Chair of BIO, joins Moira to talk about the future of Biotech from the front lines of the industry - from understanding the global Bioeconomy, to preparing for the next pandemic, and how government policy is impacting innovation. His book is, "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust".
June 16 · 34 min
How 200 Snake Bites Became an Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax
This week on BioTech Nation, a call to a man who survived hundreds of venomous snake bites helps inspire the development of an antivenom vaccine. Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of this Biotech Breakthrough – from the first telephone call through each significant step, all leading to the first breakthrough generalized antivenom vaccine in 125 years.
June 9 · 7 min
Hospital at Home? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's BioTech Nation, Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the trend of "hospital-at-home". As we see the expansion of remote healthcare technologies, could the future of hospital-like care be as on-demand as a food delivery app?
May 28 · 12 min
Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals
On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for the treatment of acute myeloid leukemia and graft vs. host disease in both adults and children. CEO Michael Metzger talks to Moira about Syndax's approach to getting the drugs across the finish line, and how they've now set their sights on additional indications and cancer therapies.
May 26 · 15 min
Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics
On this episode of BioTech Nation, Dan Schmitt of Actuate Therapeutics talks about a new kind of drug showing positive early results in hard-to-treat cancer - including adult pancreatic cancer, and two pediatric cancers. So, what’s next? Global collaborations, international trials, and efforts into different types of cancer…and they’re showing no sign of slowing down.
May 19 · 12 min
A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics
This week on BioTech Nation, Dr. Jonas Hannestad and Dr. Joanne Taylor of Gain Therapeutics join Moira to discuss a different approach to treating Parkinson's. While treatments are typically focused on relieving symptoms, Gain Therapeutics aims to stop progression of the disease itself.
May 12 · 16 min
Looking Back: A 2007 Interview with Dr. J. Craig Venter
With the recent passing of Dr. J. Craig Venter, biotech scientist and entrepreneur, we look back at Moira and David Ewing Duncan's 2007 interview with Dr. Venter. The occasion for the interview was the publication of his autobiography: "A Life Decoded: My Genome, My Life." Dr. Craig Venter was known for catalyzing the race to decode the human genome, and at the time of the interview had just decoded his own complete DNA and published it on the Internet.
May 5 · 32 min
50 Years of Genentech...Ashley Magargee, CEO, Genentech
This week on BioTech Nation, we celebrate the 50th anniversary of Genentech, the first biotech company to go public. Moira speaks with CEO Ashley Magargee about the company's journey over the last 50 years, the evolution of biotech, and where they're headed next.
April 28 · 27 min
The Global Diversity of Human Genetics...Andrew Farnum and Sarah LeBaron von Baeyer, Variant Bio
This week on BioTech Nation, Andrew Farnum and Sarah LeBaron von Baeyer discuss Variant Bio’s unique approach to collecting genetic data - working specifically with indigenous tribes and more isolated populations around the globe. Could compiling this diverse genetic data reveal something about how to develop better drugs and diagnostics? And how might those sharing their data be ethically compensated for it?
April 21 · 21 min
Testing New Drugs for Pre-Term Babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics
Dr. Marc Salzberg, CEO & Chief Medical Officer of Airway Therapeutics, talks about what they are doing to help preterm babies. It may all boil down to delivering these babies a single protein as soon as they are born.
April 14 · 12 min
Now, Near, Next...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's episode of BioTech Nation, Dr. Daniel Kraft discusses the "now-near-next" approach he uses when talking about innovation in healthcare...and beyond. From biotech breakthroughs to AI "agentification", this framework can help us see the bigger picture, and envision the possibilities of where we could be headed next.
April 7 · 22 min
Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
This week on BioTech Nation, we celebrate the life of the late Dr. Phil Low, Purdue University Distinguished Professor of Chemistry and biotech entrepreneur. In this 2017 interview, he describes the development of fluorescence-guided surgery - and why it's a game-changer for cancer treatment.
March 31 · 9 min
Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's BioTech Nation...want to go to space? Well...it's never too late to follow your dreams, and Tech Nation Health Chief Correspondent Dr. Daniel Kraft joins us to talk about who could medically qualify to climb aboard and rocket into orbit. His answers may surprise you...
March 24 · 41 min
Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
On this week's BioTech Nation...what could the future of American Healthcare look like? Moira speaks with Dr. Marschall Runge, University of Michigan Medical School Professor, about how Big Tech is quickly redefining the entire healthcare system. His book is, “The Great Healthcare Disruption: Big Tech, Bold Policy, and the Future of American Medicine.”
March 17 · 21 min
Regaining Function? Years Post-Spinal Cord Injury? Dr. Adam Rogers, CEO, NervGen Pharma
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial participants have seen increased function as much as 10 years post-trauma.
March 10 · 17 min
A New Approach to Treating ALS...Dr. Arun Swaminathan, CEO, Coya Therapeutics
On this week’s Biotech Nation, Moira speaks with Dr. Arun Swaminathan about an intervention for ALS that Coya Therapeutics is taking into phase two clinical trials. The goal? To stop progression of the disease in its tracks. It could even help in patients with Parkinson’s, Alzheimers, and Frontotemporal Dementia.
March 3 · 6 min
The Future of Early Cancer Screening...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
What if you could routinely screen for early cancer, detecting it while it's easier to treat? Tech Nation Health Chief Correspondent, Dr. Daniel Kraft discusses the latest diagnostics that could allow us to do just that. From blood tests to full-body scans, the future of cancer screening could mean finding cancer before obvious symptoms even begin...

BioTech Nation ... with Dr. Moira Gunn

A New Kind of Flu Shot...Dr. Jeff Stein, President & CEO, Cidara Therapeutics

A Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology

Insulin-Producing Cells...with no Immunosuppressants?? Dr. Steve Harr, Sana Biotechnology

Looking Forward: Biotech in the Balance? Dr. Jeremy Levin, Bioentrepreneur & Former Chair, BIO

How 200 Snake Bites Became an Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax

Hospital at Home? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals

Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics

A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics

Looking Back: A 2007 Interview with Dr. J. Craig Venter

50 Years of Genentech...Ashley Magargee, CEO, Genentech

The Global Diversity of Human Genetics...Andrew Farnum and Sarah LeBaron von Baeyer, Variant Bio

Testing New Drugs for Pre-Term Babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics

Now, Near, Next...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur

Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"

Regaining Function? Years Post-Spinal Cord Injury? Dr. Adam Rogers, CEO, NervGen Pharma

A New Approach to Treating ALS...Dr. Arun Swaminathan, CEO, Coya Therapeutics

The Future of Early Cancer Screening...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent